Cohort study on the treatment of BRAF V600E mutant metastatic colorectal cancer with integrated Chinese and western medicine

Table 1 Baseline characteristics of patients, n (%)

Project	Cohort A (n = 23)	Cohort B (n = 11)	Rank sum /χ2 /Fisher’s test	P value
Age (year)	54 (51.64)	53 (44.70)	-0.387	0.698
Gender
Male	12 (52.17)	4 (36.36)	-	0.477
Female	11 (47.83)	7 (63.63)
Primary site
Right-side colon	12 (52.17)	6 (54.55)	0.017	0.896
Left-side colon	11 (47.83)	5 (45.45)
Liver metastasis
Yes	11 (47.83)	5 (45.45)	0.017	0.896
No	12 (52.17)	6 (54.55)
Peritoneal metastasis
Yes	5 (21.74)	3 (27.27)	-	1.000
No	18 (78.26)	8 (72.73)
Chemotherapy
Yes	16 (69.57)	11 (100.00)	-	0.069
No	7 (30.43)	0 (0.00)
Targeted therapy
Yes	14 (60.87)	6 (54.55)	0.122	0.726
No	9 (39.13)	5 (45.45)